NO984342D0 - Rensing av plasmid-DNA av farmas°ytisk kvalitet - Google Patents

Rensing av plasmid-DNA av farmas°ytisk kvalitet

Info

Publication number
NO984342D0
NO984342D0 NO984342A NO984342A NO984342D0 NO 984342 D0 NO984342 D0 NO 984342D0 NO 984342 A NO984342 A NO 984342A NO 984342 A NO984342 A NO 984342A NO 984342 D0 NO984342 D0 NO 984342D0
Authority
NO
Norway
Prior art keywords
purification
plasmid dna
pharmaceutical grade
grade plasmid
pharmaceutical
Prior art date
Application number
NO984342A
Other languages
English (en)
Norwegian (no)
Other versions
NO984342L (no
Inventor
Pierre Wils
Monique Ollivier
Original Assignee
Rh Ne Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rh Ne Poulenc Rorer Sa filed Critical Rh Ne Poulenc Rorer Sa
Publication of NO984342D0 publication Critical patent/NO984342D0/no
Publication of NO984342L publication Critical patent/NO984342L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984342A 1996-03-21 1998-09-18 Rensing av plasmid-DNA av farmas°ytisk kvalitet NO984342L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique
PCT/FR1997/000472 WO1997035002A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique

Publications (2)

Publication Number Publication Date
NO984342D0 true NO984342D0 (no) 1998-09-18
NO984342L NO984342L (no) 1998-09-18

Family

ID=9490391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984342A NO984342L (no) 1996-03-21 1998-09-18 Rensing av plasmid-DNA av farmas°ytisk kvalitet

Country Status (15)

Country Link
US (1) US6730781B1 (cs)
EP (1) EP0902835A1 (cs)
JP (1) JP2000506736A (cs)
KR (1) KR100502116B1 (cs)
AU (1) AU730755B2 (cs)
BR (1) BR9708227A (cs)
CA (1) CA2249465A1 (cs)
CZ (1) CZ295587B6 (cs)
FR (1) FR2746412B1 (cs)
HU (1) HU225426B1 (cs)
IL (1) IL126268A0 (cs)
NO (1) NO984342L (cs)
SK (1) SK129198A3 (cs)
WO (1) WO1997035002A1 (cs)
ZA (1) ZA972462B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
DE60132200T2 (de) * 2000-05-26 2008-12-18 Centelion Reinigung einer tripelhelixformation mittels eines immobilisierten oligonukleotides
PL365208A1 (en) * 2001-03-23 2004-12-27 Gencell S.A. Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
FR2822476B1 (fr) * 2001-03-23 2004-04-02 Aventis Pharma Sa Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
JP2005538717A (ja) 2002-09-13 2005-12-22 ヴァレンティス,インコーポレイテッド 核酸のプレパラティブスケールの精製のための装置および方法
DK2364769T3 (en) 2003-05-30 2016-04-11 Vgxi Inc Apparatus and methods for biomaterialeproduktion
PT1664277E (pt) * 2003-09-17 2012-01-17 Aventis Pharma Sa Método de preparação de adn plasmídico de grau farmacêutico
SI1737945T1 (sl) * 2004-04-19 2011-05-31 Aventis Pharma Sa Postopek za čiščenje plazmidne DNA
JP2007532123A (ja) * 2004-04-19 2007-11-15 センテリオン 医薬品グレードのプラスミドdnaの作成方法
CA2577419A1 (en) 2004-08-16 2006-03-09 Nature Technology Corp. Improved strains of e. coli for plasmid dna production
WO2006060282A2 (en) 2004-11-30 2006-06-08 Merial Limited Mixing devices for chemical lysis of cells
US20120258502A1 (en) * 2011-04-08 2012-10-11 Vinod Pandiripally Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) * 2011-04-29 2012-11-08 The Johns Hopkins University Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0313090B1 (en) * 1987-10-22 1994-03-02 Asahi Kogaku Kogyo Kabushiki Kaisha Porous ceramic material
JPH01135792A (ja) * 1987-11-20 1989-05-29 Mitsui Toatsu Chem Inc 核酸の分離・精製方法
CA2006008C (en) * 1988-12-20 2000-02-15 Donald J. Kessler Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
AU6125294A (en) * 1993-01-13 1994-08-15 Genetics Institute Inc. Process for producing m-csf 223
US5503816A (en) * 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
JP4113580B2 (ja) * 1994-02-07 2008-07-09 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング エンドトキシンを減量又は除去する方法
US5576196A (en) * 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
DE59709915D1 (de) 1996-02-06 2003-05-28 Roche Diagnostics Gmbh Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung

Also Published As

Publication number Publication date
FR2746412A1 (fr) 1997-09-26
FR2746412B1 (fr) 1998-06-12
CZ295587B6 (cs) 2005-08-17
AU730755B2 (en) 2001-03-15
KR100502116B1 (ko) 2005-12-20
JP2000506736A (ja) 2000-06-06
HUP9902152A2 (hu) 1999-11-29
KR20000064693A (ko) 2000-11-06
NO984342L (no) 1998-09-18
SK129198A3 (en) 1999-03-12
CZ298498A3 (cs) 1999-01-13
IL126268A0 (en) 1999-05-09
US6730781B1 (en) 2004-05-04
HUP9902152A3 (en) 2001-04-28
CA2249465A1 (fr) 1997-09-25
BR9708227A (pt) 1999-07-27
HU225426B1 (en) 2006-11-28
AU2166197A (en) 1997-10-10
ZA972462B (en) 1997-09-29
WO1997035002A1 (fr) 1997-09-25
EP0902835A1 (fr) 1999-03-24

Similar Documents

Publication Publication Date Title
NO984342L (no) Rensing av plasmid-DNA av farmas°ytisk kvalitet
EP0521108A4 (en) Site specific cleavage of single-stranded dna
NO975280D0 (no) Fremgangsmåte for rensing av plasmid i stor skala
AU3672797A (en) Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
DE69212216D1 (de) Festphase-Extraktionsreinigung von DNA
FI973055A0 (fi) Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi
EP0996632A4 (en) Angiostatin fragments and method of use
EP0968223A4 (en) BIOKON JUGATION OF MACROMOLECULES
FI960469A7 (fi) DNA:ta sekvenssoivia entsyymejä
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE69731646D1 (de) Verabreichung von nukleinsäurepartikeln
NO986177L (no) FremgangsmÕte for fremstilling av terapeutisk DNA
AU4314099A (en) Novel method of large scale plasmid purification
EP1036159A4 (en) METHOD FOR PURIFYING PLASMID DNA AND PLASMID DNA THAT IS SUBSTANTIALLY FREE OF GENOMIC DNA
EP1012279A4 (en) MITOFUSIN GENES AND THEIR USE
AU2091400A (en) Prefabricated biological purification system
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
ID17125A (id) Aksi berlanjut sediaan obat tipe satuan ganda
EP0939764A4 (en) MOLECULAR GENETIC CONSTRUCTION OF PASTEURELLACEAE-BASED VACCINE STRAINS
DE69827137D1 (de) Aminoethylphenoxyessigsäure-derivate und medikamente zur schmerzlinderung und förderung der entfernung von konkrementen bei urolithiasis
GB9907553D0 (en) Purification of biological preparations
IL143499A0 (en) Liposomic niflumic acid-new transdermal anti-inflammatory medicine
BR9706942A (pt) Método de transformação genética de árvores
BR9711981A (pt) Produto farmac-utico cristalino
DE59809051D1 (de) Platte zur Unterstützung einer Deckenschalung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application